Overall rank by patents
#31,485
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
EDAP TMS France
USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, active 2017–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
8
Total patents granted
7
CPC technology areas
13.0
Avg claims per patent
+0%
5-year filing velocity
The verdict
EDAP holds 8 US patents across 7 technology areas, rank #31,485 of 50,000 tracked assignees.
- #31,485
- of 50,000 US assignees by volume
- Top 51%
- by Innovation Score (34.7/100)
- 13.0
- avg claims per patent
- +0%
- filing velocity, last 5 yrs
Portfolio overview
EDAP TMS France has been granted 8 US utility patents between 2017 and 2024, placing EDAP TMS France at rank #31,485 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.0 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, EDAP TMS France is one of the more focused assignees in the PatentsView dataset. By volume, EDAP sits between Ecential Robotics (8 patents, rank #31,481) and Efemoral Medical, Inc. (8 patents, rank #31,489) - the closest US assignees by grant volume. The composite Innovation Score of 34.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 4 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. EDAP TMS France's 13.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark EDAP TMS France against peers pursuing similar technology classes.
Who files at EDAP's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Ecential Robotics
ECENTIAL ROBOTICS
8 patents
- Echostreams Innov…
ECHOSTREAMS INNOVATIVE SOLUTIONS, LLC
8 patents
- Ecokap
ECOKAP TECHNOLOGIES LLC
8 patents
- Ecole Nationale S…
ECOLE NATIONALE SUPERIEURE DE TECHNIQUES AVANCEES
8 patents
- Edera L3C
EDERA L3C
8 patents
- Edible Arrangemen…
EDIBLE ARRANGEMENTS, LLC
8 patents
- EFC Systems
EFC SYSTEMS, INC.
8 patents
- Efemoral Medical
EFEMORAL MEDICAL, INC.
8 patents
- EDAP TMS France ◀
EDAP TMS FRANCE
8 patents
What this shows EDAP holds 8 patents at rank #31,485, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near EDAP
By rank, the assignees closest to #31,485 in granted patent volume.
- Ecential Robotics #31,481 · 8 patents
- Echostreams Innovative Solutions, Llc #31,482 · 8 patents
- Ecokap Technologies Llc #31,483 · 8 patents
- Ecole Nationale Superieure DE Techniques Avancees #31,484 · 8 patents
- Edera L3C #31,486 · 8 patents
- Edible Arrangements, Llc #31,487 · 8 patents
- EFC Systems, Inc. #31,488 · 8 patents
- Efemoral Medical, Inc. #31,489 · 8 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in EDAP's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Pacesetter, Inc. 609 in class
- ZOLL Medical Corporation 556 in class
- Koniniklijke Philips N.v. 534 in class
- Cochlear Limited 449 in class
- Varian Medical Systems, Inc. 296 in class
EDAP's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 51% higher than 49% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 12.5% |
| 2018 | 2 | 25.0% |
| 2019 | 1 | 12.5% |
| 2020 | 1 | 12.5% |
| 2022 | 1 | 12.5% |
| 2023 | 1 | 12.5% |
| 2024 | 1 | 12.5% |
Which technologies does EDAP TMS France patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing
Frequently Asked Questions
How many patents does EDAP TMS France hold?
EDAP TMS France holds 8 US granted patents filed between 2017 and 2024, spanning 7 technology areas.
What is EDAP TMS France's Innovation Score?
EDAP TMS France has an Innovation Score of 34.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does EDAP TMS France focus on?
EDAP TMS France's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 6 patents. The company has filed patents in 7 CPC subclasses total.
Is EDAP TMS France's patent filing rate increasing or decreasing?
EDAP TMS France's recent filing velocity is +0% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for EDAP TMS France's patents?
EDAP TMS France's patents average 13.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the EDAP TMS France patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
EDAP's 8 grants land it in the top 51% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - EDAP ranks #31,485 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.